Search Results - Adele Hobbs‐Muthukumar

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Dual MEK/AKT inhibition with trametinib and <scp>GSK</scp>2141795 does not yield clinical benefit in metastatic <scp>NRAS</scp>‐mutant and wild‐type melanoma

    Dual MEK/AKT inhibition with trametinib and <scp>GSK</scp>2141795 does not yield clinical benefit in metastatic <scp>NRAS</scp>‐mutant and wild‐type melanoma by Alain P. Algazi, Rosaura Esteve‐Puig, Adi Nosrati, Brian Hinds, Adele Hobbs‐Muthukumar, Prachi Nandoskar, Susana Ortiz‐Urda, Paul B. Chapman, Adil Daud

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: